TLE1 and glioblastoma: In conclusion, the identification of FOXG1:TLE1 target genes in GBM has provided evidence suggesting that this transcription repression complex promotes the tumourigenic potential of BTICs through a number of mechanisms impacting on several oncogenic pathways and has identified potentially attractive targets for antiglioma therapies.